Dare Bioscience (DARE) Reports In-Line Q2 EPS

Dare Bioscience (NASDAQ: DARE) reported Q2 EPS of ($0.10), in-line with the analyst estimate of ($0.10).

For earnings history and earnings-related data on Dare Bioscience (DARE) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Daré Bioscience to Showcase Leadership in Women's Health Innovation at BIO International Convention 2026
• BofA lists top 5 themes driving next $1tn in incremental semi sales